Post Inflammatory Hyperpigmentation, or PIH for short, is a common skin condition that affects millions of people worldwide. It's characterized by dark patches on the skin that develop after an injury, inflammation, or acne breakout. While it doesn't pose any serious health risks, PIH can be frustrating and embarrassing for those who experience it. Fortunately, there are several effective treatments available to help diminish these unsightly marks and improve the overall appearance of your skin. So if you're a medical professional looking to understand more about post inflammatory hyperpigmentation causes and treatments - keep reading!
Post Inflammatory Hyperpigmentation (PIH) is a type of hyperpigmentation that occurs as a result of skin inflammation or injury. It's a common condition, particularly among people with darker skin tones. PIH manifests as flat, dark patches on the skin that are either brown, black or red in color.
The primary cause of PIH is an overproduction of melanin - the pigment responsible for giving our skin its color. When the body detects an injury or inflammation to the skin, it produces more melanin than usual to help protect and heal damaged cells. This excess melanin can accumulate in certain areas and create dark patches.
Some conditions that can lead to PIH include acne breakouts, eczema, psoriasis, insect bites and burns. Even something as simple as scratching your skin too hard can trigger PIH.
Post inflammatory hyperpigmentation (PIH) is a common skin condition that occurs as a result of various underlying causes. The primary cause of PIH is inflammation, which triggers an overproduction of melanin in the affected area.
One common trigger for PIH is acne, which can leave behind dark spots on the skin long after the pimples have cleared up. Other possible causes include injuries or wounds, such as cuts or burns, and certain medical conditions like eczema and psoriasis.
In some cases, medications may also contribute to post-inflammatory hyperpigmentation. Certain drugs like antimalarials and chemotherapy agents are known to increase pigmentation levels in some individuals.
Furthermore, people with darker skin tones are more likely to experience PIH due to their increased production of melanin. Hormonal changes during pregnancy or with oral contraceptive use can also lead to excess pigment production and subsequent hyperpigmentation.
Treatments for Post Inflammatory Hyperpigmentation (PIH) vary depending on the severity of the condition. Mild cases can be treated with over-the-counter creams that contain ingredients like hydroquinone, kojic acid, or retinoids which work by blocking melanin production and promoting skin cell turnover. These topical treatments are usually effective in lightening dark spots caused by PIH.
For moderate to severe cases, dermatologists may recommend more aggressive treatment options such as chemical peels, microdermabrasion or laser therapy. Chemical peels involve applying a solution containing acids to exfoliate the top layers of the skin while microdermabrasion uses tiny crystals to remove dead skin cells.
Laser therapy uses intense pulses of light to target pigmented areas which helps break up melanin clusters and stimulate collagen production resulting in improved texture and tone. However, these treatments require multiple sessions and come at a higher cost than topical creams.
Post inflammatory hyperpigmentation is a common skin condition that affects many people of all ages and skin types. It can result from various causes, including acne, eczema, psoriasis, and other medical conditions.
Fortunately, there are several treatments available for post inflammatory hyperpigmentation. These include topical creams containing hydroquinone or retinoids, chemical peels, microdermabrasion and laser therapy.
If you're experiencing post inflammatory hyperpigmentation or any other skin concerns, consult with a dermatologist who can help determine the best treatment plan for your individual needs. With proper care and treatment, you can achieve clear and healthy-looking skin once again.
1.
Q&A: When will individuals be able to receive customized cancer vaccines?
2.
Canadian Group Calls for Earlier Colorectal Cancer Screening
3.
Children living near oil and gas wells face higher risk of rare leukemia, studies show
4.
Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.
5.
Talquetamab Combos Show Survival Benefit in r/r Myeloma
1.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
2.
Clinical Pharmacology of Megakaryocyte Maturation-Targeted Therapeutics
3.
The Benefits and Side Effects of Bortezomib in the Fight Against Cancer
4.
Personalized Tumor Ecological Landscapes in Oncology
5.
Unmasking the Subtle Symptoms of Colon Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
3.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Immunotherapy: A New Era in Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation